BAAM
TMO icon

Baker Avenue Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Baker Avenue Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8M Buy
35,467
+2,354
+7% +$1.13M 0.34% 70
2026
Q1 		$16.3M Buy
33,113
+6,755
+26% +$3.67M 0.37% 66
2025
Q4 		$15.3M Buy
26,358
+2,229
+9% +$1.26M 0.35% 69
2025
Q3 		$11.7M Buy
24,129
+1,095
+5% +$510K 0.28% 80
2025
Q2 		$9.34M Buy
23,034
+2,704
+13% +$1.13M 0.27% 81
2025
Q1 		$10.1M Buy
20,330
+429
+2% +$232K 0.32% 70
2024
Q4 		$10.4M Sell
19,901
-1,039
-5% -$571K 0.32% 66
2024
Q3 		$13M Buy
20,940
+7,476
+56% +$4.43M 0.41% 59
2024
Q2 		$7.45M Buy
13,464
+278
+2% +$159K 0.25% 75
2024
Q1 		$7.66M Buy
13,186
+778
+6% +$437K 0.3% 73
2023
Q4 		$6.59M Buy
12,408
+423
+4% +$205K 0.29% 79
2023
Q3 		$6.07M Buy
11,985
+130
+1% +$69.3K 0.3% 76
2023
Q2 		$6.19M Sell
11,855
-496
-4% -$268K 0.31% 70
2023
Q1 		$7.12M Sell
12,351
-413
-3% -$233K 0.38% 63
2022
Q4 		$7.03M Sell
12,764
-81
-0.6% -$42.9K 0.42% 60
2022
Q3 		$6.51M Sell
12,845
-182
-1% -$102K 0.41% 67
2022
Q2 		$7.08M Sell
13,027
-107
-0.8% -$58.9K 0.47% 59
2022
Q1 		$7.76M Buy
13,134
+30
+0.2% +$17.2K 0.4% 66
2021
Q4 		$8.74M Buy
13,104
+554
+4% +$346K 0.44% 63
2021
Q3 		$7.17M Buy
12,550
+346
+3% +$190K 0.41% 66
2021
Q2 		$6.16M Buy
12,204
+577
+5% +$272K 0.35% 73
2021
Q1 		$5.31M Buy
+11,627
New +$5.55M 0.33% 70

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baker Avenue Asset Management's TMO Position: Q2 2026 in Review

Baker Avenue Asset Management increased its Thermo Fisher Scientific (TMO) stake by 7.1% in Q2 2026, buying an estimated $1.13M and bringing the position to 35,467 shares worth $17.8M. The position accounts for 0.34% of the portfolio, ranked #70.

Baker Avenue Asset Management first reported a position in TMO in Q1 2021 and has held it in 22 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Baker Avenue Asset Management held 35,467 shares of Thermo Fisher Scientific worth $17.8M as of Q2 2026.
  • Baker Avenue Asset Management bought 2,354 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.13M.
  • Thermo Fisher Scientific made up 0.34% of Baker Avenue Asset Management's portfolio in Q2 2026, its #70 holding.
  • Baker Avenue Asset Management first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 22 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.